LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
THOUSAND OAKS, Calif., Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today ... Read More
THOUSAND OAKS, Calif., Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today ... Read More
Voluntary agreement meets the President’s four requests while also protecting ... Read More
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio ... Read More
The ABC Third Annual Policy Pulse Summit will bring together ... Read More
Cleveland (Aug 31, 2025) – The Association of Black Cardiologists ... Read More
Don't miss Cardiovascular Update 2025 — a premier educational event ... Read More
The Association of Black Cardiologists (ABC) proudly honors one of ... Read More
As cardiovascular medicine advances into the digital age, artificial intelligence ... Read More
ABC is launching a multi-phase initiative to improve cardiovascular ... Read More
The Association of Black Cardiologists (ABC), a national 501c3 nonprofit ... Read More